ACXP - צמיחת הכנסות ב-12 חודשים נגררים acurxpharma.com

Acurx Pharmaceuticals (ACXP) is developing advanced gastrointestinal antibiotics that preserve beneficial microflora and is implementing software robots for clinical data analysis. However, a narrow focus on combating C. difficile and competition from generics create risks. The relative sales growth over a 12-month period compared to last year confirms these trends, and the value of 0.00 reflects the balance of the current revenue metric.
Acurx Pharmaceuticals Inc. - פילוחים אנליטיים ומדדי מפתח (ACXP)

To build a high-quality portfolio, I use this indicator as a tool to measure the rolling year revenue expansion rate on a daily basis. This model eliminates quarterly gaps, allowing for a comparison of current revenues with the same period last year, which is critical for Acurx Pharmaceuticals (ACXP), as its clinical trial costs are growing faster than operating revenue, reflecting a lack of scaling leverage in the annual dynamics of sales proceeds over four quarters.